Literature DB >> 33746593

Concentrations of HMGB1 and Hsp70 of healthy subjects in upper and lower airway: Literature Review and Meta-analysis.

Hyun Jin Min1, Kyung Soo Kim1, Geun Joo Choi2, Hyun Kang2, Fletcher A White3.   

Abstract

Although high-mobility group box 1 and heat-shock protein 70 are implicated in airway diseases and suggested as relevant diagnostic biomarkers, their control concentrations in the airways have not yet been determined. This study aimed to evaluate concentration of healthy subjects for both these proteins in the upper and lower airways via meta-analysis. We searched MEDLINE, EMBASE, and Google Scholar for articles describing concentration of healthy subjects for these proteins. Data from healthy populations were combined using a random-effects model, and subgroup and sensitivity analyses were performed to determine between-study heterogeneity. We analyzed 22 studies involving 485 patients. Concentration of healthy subjects of high-mobility group box 1 and heat-shock protein 70 varied from "not detected" to 326.13 ng/mL and from 0.20 pg/mL to 9240.00 pg/mL, respectively, with the values showing significant heterogeneity. Subgroup analysis for high-mobility group box 1 revealed 13.63 ng/mL (95% CI 12.13-15.14), 100.31 ng/mL (95% CI -31.28-231.91), 9.54 ng/mL (95% CI 8.91-10.17), and 65.82 ng/mL (95% CI 55.51-76.14) for the lower airway, upper airway, pediatric populations, and adults, respectively, whereas that for heat-shock protein 70 revealed 20.58 pg/mL (95% CI 7.87-33.29) for the lower airway and 9240.00 ±11820 pg/mL for the upper airway. Although concentrations of healthy subjects of these proteins varied in the upper and lower airways, the levels of both these proteins were higher in the upper airway than in the lower airway, and these concentrations differed according to the age and sampling procedure. Our findings support the further evaluation of these proteins as biomarkers for airway-related diseases. © The author(s).

Entities:  

Keywords:  biomarkers; heat-shock protein 70; high-mobility group box 1 protein; meta-analysis; reference ranges

Year:  2021        PMID: 33746593      PMCID: PMC7976589          DOI: 10.7150/ijms.53500

Source DB:  PubMed          Journal:  Int J Med Sci        ISSN: 1449-1907            Impact factor:   3.738


  55 in total

1.  Damage-associated molecular pattern and innate cytokine release in the airways of competitive swimmers.

Authors:  S F Seys; V Hox; L Van Gerven; E Dilissen; G Marijsse; E Peeters; E Dekimpe; A Kasran; S Aertgeerts; T Troosters; V Vanbelle; K Peers; J L Ceuppens; P W Hellings; L J Dupont; D M Bullens
Journal:  Allergy       Date:  2015-02       Impact factor: 13.146

Review 2.  Danger-Associated Molecular Patterns (DAMPs): the Derivatives and Triggers of Inflammation.

Authors:  Seema Patel
Journal:  Curr Allergy Asthma Rep       Date:  2018-09-28       Impact factor: 4.806

3.  Soluble RAGE is deficient in neutrophilic asthma and COPD.

Authors:  M B Sukkar; L G Wood; M Tooze; J L Simpson; V M McDonald; P G Gibson; P A B Wark
Journal:  Eur Respir J       Date:  2011-09-15       Impact factor: 16.671

4.  ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition.

Authors:  H J Min; J-H Kim; J E Yoo; J-H Oh; K S Kim; J-H Yoon; C-H Kim
Journal:  Mucosal Immunol       Date:  2016-09-14       Impact factor: 7.313

5.  Pulmonary levels of high-mobility group box 1 during mechanical ventilation and ventilator-associated pneumonia.

Authors:  Marieke A D van Zoelen; Akitoshi Ishizaka; Esther K Wolthuls; Goda Choi; Tom van der Poll; Marcus J Schultz
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

6.  The role of high mobility group box1 in pulmonary fibrosis.

Authors:  Naoki Hamada; Takashige Maeyama; Tomonobu Kawaguchi; Michihiro Yoshimi; Jyutaro Fukumoto; Mizuho Yamada; Singo Yamada; Kazuyoshi Kuwano; Yoichi Nakanishi
Journal:  Am J Respir Cell Mol Biol       Date:  2008-04-25       Impact factor: 6.914

7.  Gradual increase of high mobility group protein b1 in the lungs after the onset of acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Masahito Ebina; Hiroyuki Taniguchi; Taku Miyasho; Shingo Yamada; Naoko Shibata; Hiromitsu Ohta; Shu Hisata; Shinya Ohkouchi; Tsutomu Tamada; Hidekazu Nishimura; Akitoshi Ishizaka; Ikuro Maruyama; Yoshinori Okada; Kondo Takashi; Toshihiro Nukiwa
Journal:  Pulm Med       Date:  2011-02-21

8.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range.

Authors:  Xiang Wan; Wenqian Wang; Jiming Liu; Tiejun Tong
Journal:  BMC Med Res Methodol       Date:  2014-12-19       Impact factor: 4.615

9.  HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4.

Authors:  Leonarda Di Candia; Edith Gomez; Emilie Venereau; Latifa Chachi; Davinder Kaur; Marco E Bianchi; R A John Challiss; Christopher E Brightling; Ruth M Saunders
Journal:  J Allergy Clin Immunol       Date:  2017-03-01       Impact factor: 10.793

Review 10.  Damage-Associated Molecular Patterns in Inflammatory Diseases.

Authors:  Jong Seong Roh; Dong Hyun Sohn
Journal:  Immune Netw       Date:  2018-08-13       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.